Some of the most remarkable stories in science begin in the most unlikely of places.
Over 40 years ago, in a modest hen house in County Antrim, Northern Ireland, Dr Peter FitzGerald founded Randox with a vision of changing global healthcare and placing diagnostics at the core of every clinical decision.
Today, that vision has grown into the UK's largest diagnostic company, supporting healthcare systems and laboratories across the globe.
This groundbreaking innovation represents a fundamental reimagining of how diagnostic testing can be performed. Using protein-based arrays on a tiny biochip, this rapid multi-analyte analyser can simultaneously test for multiple conditions from a single patient sample.

Faster Decisions
Simultaneous detection of 100 markers

Greater Precision
Highly accurate multi-analyte analysis

Personalised Care
Enables targeted treatment pathways

By identifying the underlying cause of disease rather than simply symptoms, Biochip Array Technology enables clinicians to make truly informed, personalised treatment decisions.

3,000+ employees representing 44 nationalities, including thousands of scientists, engineers and healthcare professionals.
A culture that celebrates neurodiversity and unconventional thinking, recognising that the most transformative breakthroughs often come from minds that see the world from a different angle.
When the pendemic struck, we acted fast to support global healthcare systems.